Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry

SLAS DISCOVERY(2022)10.1016/j.slasd.2021.12.005Source: DataRank Database

A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry is a research paper published in SLAS DISCOVERY (2022). On theSindex it has a DataRank of 0. It has been cited 26 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access26 citations

Download PDF

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 2.51)OA: goldTopics (45)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Manisha Pradhan ORCID,Kirill Gorshkov ORCID,Jennifer D. Petersen ORCID,Min Shen ORCID,Hui Guo ORCID

Live enrichment

PubMed:35086793 PMC:PMC8720380 OpenAlex:https://openalex.org/W4220655955

National Institutes of Health

Grant: R01AI35270

NIAID NIH HHS

Grant: R01 AI135270

National Institutes of Health

Grant: 5R01AR035270-02

COPING WITH OSTEOARTHRITIC KNEE PAIN

National Center for Advancing Translational Sciences

Eunice Kennedy Shriver National Institute of Child Health and Human Development

National Institute of Child Health and Human Development

FWCI

2.51

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

goldLicense: cc-by

journalhttp://slas-discovery.org/article/S2472555221000241/pdf

publisherhttp://slas-discovery.org/article/S2472555221000241/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2472555221000241?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2472555221000241?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.slasd.2021.12.005

Fields of Study

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingViral Infections and Outbreaks Research0301 basic medicine03 medical and health sciencesAntiviral AgentsHEK293 CellsHigh-Throughput Screening AssaysHumansSARS-CoV-2Virus Internalization

MeSH Terms

SARS-CoV-2Antiviral AgentsHumansVirus InternalizationHigh-Throughput Screening AssaysHEK293 Cells

Keywords

High-throughput screeningVirologyHEK 293 cellsLuciferaseViral entryBiologyChemistryVirusTransfectionCell cultureBiochemistryViral replicationGeneticsHigh throughput screeningDrug Repurposing ScreenCovid-19Sars-cov-2Pseudotyped Particle Viral Entry AssayMedicine (General)Virus InternalizationAntiviral AgentsArticleHigh-Throughput Screening AssaysR5-920HEK293 CellsHumansTP248.13-248.65Biotechnology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry

FAIR Checklist

Authors (16)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)